Cicero Diagnostics, Inc. Announces the Release of MyReceptiva™ – An Endometriosis Detection Test capable of detecting over 90% of endometriosis cases.
February 25, 2025 05:45 ET
|
Cicero Diagnostics
Cicero Diagnostics unveils MyReceptiva™, a $585 non-invasive test detecting over 90% of endometriosis cases, with quick results from an endometrial biopsy.
Introducing babybubble: A Revolutionary NEW Parenting App Combining Expert Advice with Real-World Vetted Guidance from a Community of Moms Around the Globe Hits 500k Downloads
December 11, 2024 13:07 ET
|
babybubble
Introducing babybubble: A Revolutionary NEW Parenting App Combining Expert Advice with Real-World Vetted Guidance from a Community of Moms Around the Globe
ARC Fertility and Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits for Employers and Workforces
October 08, 2024 10:11 ET
|
ARC Fertility
ARC Fertility & Sapyen Announce Strategic Partnership to Revolutionize Male Fertility Testing, Expanding Reproductive Health Benefits: Employers & Workers
Global Fertility Services Market Analysis Report 2024-2030: Focus on United States, Canada, Germany, United Kingdom, France, Italy, China, Japan, South Korea, India
April 10, 2024 05:38 ET
|
Research and Markets
Dublin, April 10, 2024 (GLOBE NEWSWIRE) -- The "Global Fertility Services Market (2024 Edition): Analysis By Gender (Male, Female), Treatment Type, Channel, Services , By Region, By Country: Market...
Saudi Arabia In-Vitro Fertilization (IVF) Market Report 2023-2028: Driven by Demand for Fertility Treatments and Technological Advancements
February 07, 2024 04:12 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia In-Vitro Fertilization Market By Technique, By Reagent, By Instrument, By Infertility, By Embryo, By Application, By End-User, By Region,...
GCC In-Vitro Fertilization (IVF) Market Report 2023-2033: Regional Growth Analysis by Procedure, End User & Product, Featuring Profiles of Prominent Market Players
January 30, 2024 09:29 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "GCC IVF Market: Focus on Procedure, End User, Product, and 8 Countries' Data - Analysis and Forecast, 2023-2033" report has been added to ...
Polycystic Ovary Syndrome (PCOS) Treatment Market Forecast: Projected Substantial Growth by 2031
January 25, 2024 14:07 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Polycystic Ovary Syndrome (PCOS) Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology,...
Global Contraceptive Devices Market Report 2023-2028: Emphasis on STD Prevention and Family Planning Catalyzes Demand
January 25, 2024 11:05 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution...
Global $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Region
January 11, 2024 12:43 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Women's Health Market Size, Share & Trends Analysis Report by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis &...
Breast Cancer Drugs Global Market Report 2024, Featuring Profiles of Key Players Novartis, AstraZeneca, Eli Lilly, Biocon, Merck and MacroGenics
December 14, 2023 11:03 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "Breast Cancer Drugs Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The breast cancer drugs market size is set to to...